BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Abliva - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://abliva.com
X-WR-CALDESC:Events for Abliva
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220222
DTEND;VALUE=DATE:20220225
DTSTAMP:20260409T210805
CREATED:20211111T134348Z
LAST-MODIFIED:20211111T134348Z
UID:2973-1645488000-1645747199@abliva.com
SUMMARY:Mitochondria-Targeted Drug Development Summit
DESCRIPTION:Abliva will attend and present at the Mitochondria-Targeted Drug Development Summit in Boston\, MA\, USA. The event will be held on 22 – 24 February 2022. \nCEO Ellen Donnelly will be presenting in the session Patient-Focused Drug Development for Mitochondrial Disease. \nSynopsis: \n\nHighlighting the impact of patient input on research and development at Abliva\nProviding an overview of the multiple therapeutic options for mitochondrial disease being pursued at Abliva\nPresenting placebo controlled PMD patient data from our lead asset\, KL1333
URL:https://abliva.com/event/mitochondria-targeted-drug-development-summit/
LOCATION:Hyatt Regency Boston/Cambridge\, 575 Memorial Dr\, Cambridge\, Massachusetts\, 02139\, United States
CATEGORIES:Scientific event
END:VEVENT
END:VCALENDAR